SEATTLE II was a prospective, single-arm, multi-center trial of the EkoSonic Endovascular System (EKOS Corporation) used with alteplase, a tissue plasminogen activator (tPA), for treatment of acute pulmonary embolism.
SEATTLE II was a prospective, single-arm, multi-center trial of the EkoSonic Endovascular System (EKOS Corporation) used with alteplase, a tissue plasminogen activator (tPA), for treatment of acute pulmonary embolism.
SEATTLE II was a prospective,...